Kura Oncology (KURA) EBITDA (2010 - 2026)
Kura Oncology (KURA) posted quarterly EBITDA of -$78.8 million for Q1 2026, down 21.82% year-over-year from -$100.8 million in Q1 2025, and up 2.19% quarter-over-quarter from -$80.6 million in Q4 2025.
Kura Oncology (KURA) EBITDA (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has reported EBITDA for 8 consecutive years, with -$78.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA fell 21.82% year-over-year to -$78.8 million; the TTM figure through Mar 2026 stood at -$274.1 million (down 1794.43% YoY), while the FY2025 annual figure was -$303.6 million, down 57.16% from the prior year.
- EBITDA climbed to -$78.8 million in Q1 2026 per KURA's latest filing, from -$80.6 million in the prior quarter.
- Across five years, EBITDA topped out at $154.6 million in Q4 2024 and bottomed at -$80.6 million in Q4 2025.
- Historically, EBITDA has averaged -$37.5 million across 3 years, with a median of -$54.0 million in 2024.
- On a YoY basis, EBITDA climbed as much as 18.44% in 2025 and fell as far as 152.14% in 2025.
- Kura Oncology's EBITDA stood at $154.6 million in 2024, then sank by 152.14% to -$80.6 million in 2025, then gained by 2.19% to -$78.8 million in 2026.
- Business Quant data shows KURA's EBITDA at -$78.8 million in Q1 2026, -$80.6 million in Q4 2025, and -$73.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Kura Oncology | 966.11 Mn | 966.11 Mn | 20.63 Mn | -73.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -73.01 Mn |
| Mar 31, 2026 | -78.82 Mn |
| Dec 31, 2025 | -80.58 Mn |
| Sep 30, 2025 | -73.62 Mn |
| Jun 30, 2025 | -41.05 Mn |
| Mar 31, 2025 | -64.70 Mn |
| Dec 31, 2024 | 154.56 Mn |
| Sep 30, 2024 | -53.99 Mn |
| Jun 30, 2024 | -50.34 Mn |
| Mar 31, 2024 | -49.03 Mn |
| Dec 31, 2014 | -9,762.00 |
| Sep 30, 2014 | -4,764.00 |
| Jun 30, 2014 | -5,242.00 |
| Mar 31, 2014 | -4,138.00 |
| Dec 31, 2013 | -8,087.00 |
| Sep 30, 2013 | -4,475.00 |
| Jun 30, 2013 | -5,456.00 |
| Mar 31, 2013 | -4,716.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,728.00 |